Researchers at QIMR Berghofer and Peter MacCallum Cancer Centre have discovered a new vital clue to improving immunotherapy to fight blood cancers such as leukaemia and myeloma. A new type of immunotherapy called T cell engaging bispecific therapy has shown great potential for treating blood cancers and is already being widely tested in clinical trials. […]